Taglich Brothers Initiates Nexeon Medsystems Inc.

NEW YORK, Jan. 16, 2018 (GLOBE NEWSWIRE)  Taglich Brothers, Inc. announces that it has initiated coverage of Nexeon Medsystems Inc. (OTC:NXNN). Nexeon MedSystems Inc., headquartered in Dallas, Texas, is a medical device company developing a neurostimulator technology platform for the treatment of disorders through the electrical stimulation of neural tissues.  The company’s first application of its Nexeon Neurostimulation System will be for the treatment of chronic medical conditions such as Parkinson’s and associated diseases in Europe.  The company’s Belgian-based Medi-Line subsidiary provides
http://bit.ly/2FLP4jN